🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Вирџинија › Charlottesville

Kliničke studije za Akutna mijeloidna leukemija u gradu Charlottesville, VA

16 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Charlottesville i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Virginia Cancer Center, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Тражи се учесникФаза 3
  • University of Virginia School of Medicine, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Virginia Cancer Center, Charlottesville
Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Тражи се учесникФаза 1
  • University of Virginia Cancer Center, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT04716452

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Тражи се учесникФаза 2
  • University of Virginia Cancer Center, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Virginia Cancer Center, Charlottesville
Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Тражи се учесникФаза 3
  • University of Virginia Cancer Center, Charlottesville
6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Тражи се учесникФаза 3
  • University of Virginia Cancer Center, Charlottesville
Узраст од 1 до 25 · Оба пола · Ажурирано 4. 9. 2026. · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2
  • University of Virginia Cancer Center, Charlottesville
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Тражи се учесникФаза 1
  • University of Virginia Comprehensive Cancer Center, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Тражи се учесникОпсервациона студија
  • University of Virginia, Charlottesville
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

Тражи се учесникФаза 1
  • University of Virginia, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 11. 5. 2026. · NCT07270978

Cardioprotection in AML

Тражи се учесникФаза 2
  • University of Virginia, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 5. 5. 2026. · NCT04977180

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Тражи се учесникФаза 1/2
  • University of Virginia, Charlottesville
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT05732103

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Тражи се учесникФаза 1/2
  • University of Virginia, Charlottesville
Узраст 12 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Тражи се учесникФаза 2
  • University of Virginia, Charlottesville
Узраст од 18 до 66 · Оба пола · Ажурирано 17. 3. 2026. · NCT06859424

Studije za Akutna mijeloidna leukemija u drugim gradovima

Ostale studije u gradu Charlottesville

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.